These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 7037821)
41. Basic peptide with insulin-like activity in human serum. Sasaki N; Okabe T; Imai Y; Matsuzaki F; Kosaka K; Wakai K; Tsushima T Endocrinol Jpn; 1981 Apr; 28(2):157-67. PubMed ID: 7030722 [TBL] [Abstract][Full Text] [Related]
42. [Somatomedins and their significance in pediatrics]. Vetter U; Teller WM Klin Padiatr; 1985; 197(5):378-85. PubMed ID: 3906254 [TBL] [Abstract][Full Text] [Related]
43. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status. Mukherjee A; Murray RD; Teasdale GM; Shalet SM Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963 [TBL] [Abstract][Full Text] [Related]
44. Hyperprolactinemia is associated with increased immunoreactive somatomedin C in hypopituitarism. Clemmons DR; Underwood LE; Ridgway EC; Kliman B; Van Wyk JJ J Clin Endocrinol Metab; 1981 Apr; 52(4):731-5. PubMed ID: 7193685 [TBL] [Abstract][Full Text] [Related]
45. Purification of somatomedin-C/insulin-like growth factor I. Svoboda ME; Van Wyk JJ Methods Enzymol; 1985; 109():798-816. PubMed ID: 3887105 [No Abstract] [Full Text] [Related]
46. Somatomedins in pregnancy: a cross-sectional study of insulin-like growth factors I and II and somatomedin peptide content in normal human pregnancies. Wilson DM; Bennett A; Adamson GD; Nagashima RJ; Liu F; DeNatale ML; Hintz RL; Rosenfeld RG J Clin Endocrinol Metab; 1982 Nov; 55(5):858-61. PubMed ID: 6749878 [TBL] [Abstract][Full Text] [Related]
47. Acquired prolactin deficiency indicates severe hypopituitarism in patients with disease of the hypothalamic-pituitary axis. Mukherjee A; Murray RD; Columb B; Gleeson HK; Shalet SM Clin Endocrinol (Oxf); 2003 Dec; 59(6):743-8. PubMed ID: 14974916 [TBL] [Abstract][Full Text] [Related]
48. Somatomedin inhibitor in uremia. Phillips LS; Fusco AC; Unterman TG; del Greco F J Clin Endocrinol Metab; 1984 Oct; 59(4):764-72. PubMed ID: 6384255 [TBL] [Abstract][Full Text] [Related]
49. Determinants of serum leptin levels in Cushing's syndrome. Widjaja A; Schürmeyer TH; Von zur Mühlen A; Brabant G J Clin Endocrinol Metab; 1998 Feb; 83(2):600-3. PubMed ID: 9467580 [TBL] [Abstract][Full Text] [Related]
50. Skeletal metabolism and body composition in Cushing's syndrome. Aloia JF; Roginsky M; Ellis K; Shukla K; Cohn S J Clin Endocrinol Metab; 1974 Dec; 39(6):981-5. PubMed ID: 4214835 [No Abstract] [Full Text] [Related]
51. Plasma forms of somatomedin and the binding protein phenomenon. Hintz RL Clin Endocrinol Metab; 1984 Mar; 13(1):31-42. PubMed ID: 6202446 [TBL] [Abstract][Full Text] [Related]
52. Insulin-like growth factor I/somatomedin-C (IGF-I/SM-C) and glucocorticoids synergistically regulate mitosis in competent human fibroblasts. Conover CA; Dollar LA; Hintz RL; Rosenfeld RG J Cell Physiol; 1983 Aug; 116(2):191-7. PubMed ID: 6306016 [TBL] [Abstract][Full Text] [Related]
53. Induction of immunoreactive somatomedin C human serum by growth hormone: dose-response relationships and effect on chromatographic profiles. Copeland KC; Underwood LE; Van Wyk JJ J Clin Endocrinol Metab; 1980 Apr; 50(4):690-7. PubMed ID: 7189195 [No Abstract] [Full Text] [Related]
54. Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate. Rosenfeld RG; Kemp SF; Hintz RL J Clin Endocrinol Metab; 1981 Sep; 53(3):611-7. PubMed ID: 7021582 [No Abstract] [Full Text] [Related]
55. Insulin-like growth factor I/somatomedin C (IGF-I/Sm C): comparison of natural, solid phase synthetic and recombinant DNA analog peptides in two radioligand assays. Schalch D; Reismann D; Emler C; Humbel R; Li CH; Peters M; Lau E Endocrinology; 1984 Dec; 115(6):2490-2. PubMed ID: 6389098 [TBL] [Abstract][Full Text] [Related]
57. Evidence for two species of insulin-like growth factor II (IGF II and "big" IGF II) in human spinal fluid. Haselbacher G; Humbel R Endocrinology; 1982 May; 110(5):1822-4. PubMed ID: 7042316 [TBL] [Abstract][Full Text] [Related]
58. Specific water-soluble binding sites for serum insulin-like peptides in human and animal tissues. Guyda HJ; Posner BI Endocrinology; 1980 Jan; 106(1):113-9. PubMed ID: 7349949 [No Abstract] [Full Text] [Related]
59. Immunoreactive somatomedin B (RIA-B) in the circulation of healthy adults and patients with endocrine disorders. Tham A; Sara VR; Bäckström M; Hall K; Kallner G; Ljunggren JG; Wetterberg L Horm Metab Res; 1986 Oct; 18(10):706-9. PubMed ID: 3781477 [TBL] [Abstract][Full Text] [Related]
60. Plasma levels of atrial natriuretic hormone in Cushing's syndrome. Yamaji T; Ishibashi M; Yamada A; Takaku F; Itabashi A; Katayama S; Ishii J; Takami M; Fukushima T J Clin Endocrinol Metab; 1988 Aug; 67(2):348-52. PubMed ID: 2969001 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]